---

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.

**FORM 10-KSB**

[ X ] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE  ACT OF 1934

For the fiscal year ended **September 30, 2002**

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934

Commission File No. **2-94704-NY**

**MedXLink, Corp.**(Formerly NTC Holdings, Inc.)
(Exact name of Registrant as specified in its charter)

**4766 South Holladay Boulevard, Holladay, Utah 84117**(Address and zip code of principal executive offices)

Registrant's telephone number, including area code:**(801) 273-9300**

Securities registered pursuant to Section 12(b) of the Act: **NONE**Securities registered pursuant to Section 12(g) of the Act: **NONE**

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required
to file such reports, and (2) has been subject to such filing requirements for the past 90 days. **[ X ] Yes [ ] No**

Revenue for the year ended September 30, 2002: $ 0.

As of January 13, 2003 it is unclear as to the aggregate market value of the voting stock held by
non-affiliates of the Registrant. This is due to the low or almost non-existing trading of the
Registrant's Securities.



---

**PART I**

---

**ITEM 1. DESCRIPTION OF BUSINESS**

NTC Holdings Inc., ("the Company")was organized in May 1983 in the State of New York
under the name "National Thoroughbred Corporation." Subsequently, the name was changed to
"NTC Holdings, Inc." Although originally formed to engage in purchasing, breeding and selling
Thoroughbred horses, the company's management anticipates merging with an as yet unidentified
on-going business in the future.

The board of directors feel that the Company does not meet the criteria of a development
stage company (as defined in SFAS 7 "*Accounting and Reporting by Development Stage
Enterprises*") primarily because it is not currently producing or marketing a product or service.
However, the Company is currently seeking a business opportunity to merge with or acquire, but to
date has not located any such business opportunities.

In seeking a business opportunity to merge with or acquire, management is reviewing various
business plans. Management has not limited their review of plans or exploration of acquisitions to
any particular industry or service sector.   Management has not yet identified a business to complete
such a transaction with and the Company has not entered into any binding agreements for an
acquisition or merger. There is no assurance that the Company will be successful in finding any
business opportunity to merge with or acquire.

On July 5, 2002 Articles of Merger were filed with the state of Nevada, merging NTC
Holdings, Inc. a New York corporation into Medeport, Inc. a Nevada Corporation for the purpose
of changing  domicile.  On July 12, 2002 the name was changed from Medeport, Inc. to MedXLink
Corp.  The shareholders agreed to eliminate the Class A Preferred stock of 1 share ($.001 par value)
and the Class B Preferred stock of 1,000,000 shares ($.001 par value).  Both classes of stock had no
shares issued and outstanding.

Effective July 21, 2002 the Company entered into an agreement to acquire all of the equity
of eHDL, Inc. ("eHDL").  In anticipation of the transaction the Company sold approximately
$195,000 in debentures and loaned the proceeds to eHDL.  The transaction was not scheduled to
close, however, until and unless eHDL obtained 1) $1 million in funding, 2) converted its existing
debt to equity and 3) obtained audited financial statements.  Based on the current financial status of
eHDL, management does not anticipate it will complete the acquisition of eHDL.  Consequently, the
Company may have to seek bankruptcy protection to resolve debenture obligations created in
anticipation of acquiring eHDL.  Only if the debenture obligations are resolved will the Company be
able to proceed with finding a business opportunity to merge with or acquire. Additionally, because
of numerous representations made by eHDL to the Company to forestall seeking a new business
opportunity, and because of the debt owed by eHDL to the Company, management is exploring the
need to commence litigation.

**ITEM 2. DESCRIPTION OF PROPERTY**

The Company currently operates from the office of the Company's legal counsel and pays
no rent or expenses.

**ITEM 3. LEGAL PROCEEDINGS**

Not applicable

**ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITIES HOLDERS**

A special shareholders meeting was held on May 31, 2002.  The shareholders authorized the
following: 1) a reverse split of up to 100:1 effective immediately; 2) a change in domicile from New
York to Nevada; 3) an amendment to the articles of incorporation effecting a change in the
authorized common shares from 25 million to 100 million and eliminate the Class A and Class B
preferred stock; 4) a change in the Company's name to be decided at a future date.  All items were
approved by the shareholders and the Company effected a reverse split of 100 to 1.



---

**PART II**



---

The Company is not currently trading in any public markets.  The symbol for the Company
is MXLK and trades on the OTC Bulletin Board.  As of January 13, 2003, the Company had
approximately 167 shareholders of record.

The Company has not declared any cash dividends on its Common Stock since inception and
its Board of Directors has no present intention of declaring any dividends. For the foreseeable future,
the Company intends to retain all earnings, if any, for use in the development and expansion of its
business.

**ITEM 6. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS**

**Financial Condition**

Total stockholders' deficit for the year ending September 30, 2002 was $(110,854), as
compared to $(24,163) at September 30, 2001. The Company has no operating capital for future
operations.

**Liquidity and Capital Resources**

The Company has minimal assets and is currently in the process of looking for business
opportunities to merge with or acquire. During the next twelve months, the Company will need to
raise additional capital through private funding to meet the financial needs of being a reporting
company and to meet the obligations of the current accounts payable.  Historically, the Company
has been successful in either raising operational capital or extending the present loans, or a
combination of both. There is no guarantee that the Company will be successful in obtaining
necessary funding to develop any business opportunities.

During the fourth fiscal quarter the Company entered into an agreement to acquire all of the
equity of eHDL, Inc.  Closing of the acquisition would  not take place, if at all, until certain events
have occurred.  In anticipation of completing the acquisition, the Company sold $195,000 in
convertible debentures at an interest rate of 8% a.p.r. and due one year from date of issue to eHDL
investors.  The Company loaned all of the debenture proceeds to eHDL in an 8% a.p.r. promissory
note due on demand and eHDL has agreed to indemnify the Company from any financial
responsibility of the debentures.  It is unclear at this time whether the Company will have to repay
the debentures or honor a conversions due to the lack of eHDL's ability to perform on its guarantee.
In planning for its short term capital needs, the Company assumes that it will not have to repay the
debentures.  Should that change, the Company may have to seek bankruptcy protection.

The Company has approached DHM Enterprises, LLC for an extension on the note that is
due March 31, 2002. DHM Enterprises, LLC has agreed toextend the due date of the note to
September 30, 2003.

**Results of Operations**

The Company reported a net loss of $(88,691) for the year ended September 30, 2002,
compared to a loss of $(19,507) for the previous year. The Company anticipates very little or no
overhead from future operations until a successor business can be acquired or merged.

**ITEM 7. FINANCIAL STATEMENTS**

(a)(1) The following financial statements of the Company and its subsidiaries have been filed as part
of this report:

Independent Auditors' Report

Balance Sheets as of September 30, 2002.

Statements of Operations for the years ended September 30, 2002 and September 30, 2001.

Statement of Stockholders' Equity for the period from October 1, 2000 to September 30, 2002.

Statement of Cash Flows for the years ended September 30, 2002 and September 30, 2001.

Notes to Financial Statements.

(2) Schedules are omitted because of the absence of conditions under which they are required or
because the required information is given in the financial statements or notes thereto.

---



**MedXLink, Corp.**

INDEPENDENT AUDITOR'S REPORT

We have audited the accompanying balance sheet of MedXLink, Corp., (a Nevada corporation) as
of September 30, 2002 and 2001 and the related statements of operations, stockholders' equity, and
cash flows for the years then ended.  These financial statements are the responsibility of the
company's management.  Our responsibility is to express an opinion on these financial statements
based on our audit.

We conducted our audit in accordance with generally accepted auditing standards, in the United
States of America.  Those standards require that we plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free of material misstatement.  An audit
includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial
statements.  An audit also includes assessing the accounting principles used and significant estimates
made by management, as well as evaluating the overall financial statement presentation.  We believe
that our audit provides a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the
financial position of MedXLink, Corp. at September 30, 2002 and 2001, and the results of its
operations and cash flows for the years then ended in conformity with generally accepted accounting
principles, in the United States of America.

The accompanying financial statements have been prepared assuming that the Company will
continue as a going concern.  As discussed in Note 9 to the financial statements, the Company has
minimal assets and no operations and is dependent upon financing to continue operations.  These
factors raise substantial doubt about its ability to continue as a going concern.  Management's plans
in regard to these matters are also described in the Note 9.  The financial statements do not include
any adjustments that might result from the outcome of this uncertainty.

Salt Lake City, Utah
January 13, 2003

---



**MedXLink, Corp**Balance Sheet

Current Assets

Cash                                                                             
$		63                             
$		450

Interest Receivable                                                       
3,391                                   
-

Note Receivable (Note 5)                                         
195,000-

Total Assets                                                           
$		198,454                            
$		450



Accounts Payable                                                      
79,627                            
3,813

Taxes Payable (Note 3)                                             
2,400                                
300

Interest Payable (Note 4)                                            
7,271                            
1,733

Notes Payable (Note 4)                                           
220,01018,767

Total Current Liabilities                                             
309,308                          
24,613

Stockholders' Equity (Deficit)

Common Stock; 100,000,000 Shares Authorized;
at $.001 Par Value; 2,256,594 and 250,000 Shares
Issued and Outstanding, Respectively                           
2,257                             
250
Capital in Excess of Par Value                                   
293,885                     
293,892
Retained Deficit                                                       
(406,996)                   
(318,305)

Total Stockholders' Equity (Deficit)                            
(110,854)                   
(24,163)







---



**MedXLink, Corp.**

September 30,            September 30,	                                                                                        
20022001

Revenue                                                                           
$	-                               
$	-

General & Administrative                                                    
85,74418,295

Total Expenses                                                                   
85,744                        
18,295

Net Income (Loss) from Operations                                   
(85,744)                    
(18,295)

Other Income (Expenses)

Interest Income                                                                     
3,391                            
-

Interest Expense                                                                   
(5,538)                         
(412)

Total Expenses                                                                     
(2,147)                          
(412)

Income (Loss) - Before Taxes                                              
(87,891)                    
(18,707)

Taxes (Note 3)                                                                           
800                           
800

Net Income (Loss)                                                             
$		(88,691)               
$		(19,507)

Net (Loss) Per Common Share                                          
$		(.35)                     
$		(.08)

Weighted Average Outstanding Shares                                   
251,445                 
232,083



---



**MedXLink, Corp.**Statement of Stockholders' Equity
From October 1, 2000 through September 30, 2002

Capital In
                                                                              
Common Stock              		Excess of			Retained                                                                               
Shares			Amount			Par Value			Deficit

Balance, October 1, 2000                                      
225,908 	$		226 	$		285,916 	$		(298,798)

Shares Issued for Cash at $.0011 Per Share                                      
18,092 			18 			1,982

Shares Issued for Cash at $.01 Per Share                                              
6,000 			6 			5,994

Loss for the Year Ended September 30, 2001                                                
(19,507)

Balance, September 30, 2001                                      
250,000 			250 			293,892 			(318,305)

Rounding Due to 1 to 100 Reverse Stock Split                                            
6,594 			7 			(7)

Shares Issued for Relief of Debt at $.001 Per Share                              
2,000,000 			2,000

Loss for the Year Ended September 30, 2002 (88,691)

Balance, September 30, 2002                          
2,256,594 	$		2,257 	$		293,885 	$		(406,996)

---



For the Years Ended
                                                                                      
September 30,		September 30,	                                                                                               
2002             
2001

Cash Flows from Operating Activities

Net (Loss)                                                                          
$		(88,691)       $		(19,507)

Changes in Operating Assets & Liabilities;
Stock Issued for Relief of Payable                                             
2,000              
-

(Increase) in Interest Receivable                                               
(3,391)             
-

Increase (Decrease) in Accounts Payable/Interest Payable        
81,352            (883)

Increase (Decrease) in Taxes Payable                                        
2,100            
(800)

Net Cash Provided (Used) by Operating Activities                   
(6,630)         (21,190)

Cash Flows from Investing Activities

Payment for Note Receivable                                               
(195,000)               
-

Cash Flows from Financing Activities

Proceeds from Notes Payable                                                
201,243               
-

Issuance of Note Payable for Services                                        
-                 
13,640

Issuance of Common Stock for Cash                                          
-                   
8,000

Increase (Decrease) in Cash                                                       
(387)              
450

Cash, Beginning of Period                                                            
450                
-

Cash, End of Period                                                                   
$		63             
$		450

Supplemental Disclosure

Interest                                                                                      
$	-                 
$	-

Income Taxes (Including Interest & Penalties)                               
-                  
800



---



**MedXLink, Corp.**

**NOTE 1 - Corporate History**

The Company was organized in May 1983 in the State of New York under the name of "National
Thoroughbred Corporation."  Subsequently, the name was changed to "NTC Holdings, Inc."
Although originally formed to engage in purchasing, breeding and selling Thoroughbred horses, the
company's management anticipates merging with an as yet unidentified on-going business in the
future.

On July 5, 2002, Articles of Merger were filed with the state of Nevada, merging NTC Holdings, Inc.,
(a New York corporation) into Medeport, Inc., (a Nevada Corporation) for the purpose of changing
domicile.  On July 12, 2002, the name was changed from Medeport, Inc., to MedXLink, Corp.  The
shareholders agreed to eliminate the Class A Preferred Stock of one share ($.001 par value) and the
Class B Preferred Stock of 1,000,000 shares ($.001 par value).  Both classes of stock had no shares
issued or outstanding.

Effective July 21, 2002, the Company entered into an agreement to acquire all of the equity of eHDL,
Inc., ("eHDL").  The transaction is not scheduled to close, however, until and unless eHDL obtains
the following; one million dollars in funding, converts its existing debt to equity and obtains audited
financial statements.

**NOTE 2 - Significant Accounting Policies**

A.	The Company uses the accrual method of accounting.

B.	Revenues and directly related expenses are recognized in the period when the goods are
shipped to the customer.

C.	The Company considers all short term, highly liquid investments that are readily convertible,
within three months, to known amounts as cash equivalents.  The Company currently has
no cash equivalents.

D.	Basic Earnings Per Shares are computed by dividing income available to common
stockholders by the weighted average number of common shares outstanding during the
period.  Diluted Earnings Per Share shall be computed by including contingently issuable
shares with the weighted average shares outstanding during the period.  When inclusion of
the contingently issuable shares would have an antidilutive effect upon earnings per share no
diluted earnings per share shall be presented.

E.	Estimates:   The preparation of the financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that affect
the amounts reported in the financial statements and accompanying notes.  Actual results
could differ from those estimates.



---



**MedXLink, Corp.**

The Company adopted Statement of Financial Standards No. 109 "Accounting for Income taxes"
in the fiscal year ended September 30, 1999 and was applied retroactively.

Statement of Financial Accounting Standards No. 109 "*Accounting for Income Taxes*" requires an
asset and liability approach for financial accounting and reporting for income tax purposes.  This
statement recognizes (a) the amount of taxes payable or refundable for the current year and (b)
deferred tax liabilities and assets for future tax consequences of events that have been recognized in
the financial statements or tax returns.

Deferred income taxes result from temporary differences in the recognition of accounting
transactions for tax and financial reporting purposes.   There were no temporary differences at
September 30, 2002 and earlier years; accordingly, no deferred tax liabilities have been recognized
for all years.

The Company has cumulative net operating loss carryforwards of approximately $332,000 at
September 30, 2002.  No effect has been shown in the financial statements for the net operating loss
carryforwards as the likelihood of future tax benefit from such net operating loss carryforwards is
highly improbable.  Accordingly, the potential tax benefits of the net operating loss carryforwards,
estimated based upon current tax rates at September 30, 2002 have been offset by valuation reserves
of the same amount.

The Company has available approximately $332,000 in net operating loss carryforwards that will
begin to expire in the year 2003.  The Company has accrued $800 per year minimum state income
taxes while it was a New York Corporation.

**NOTE 4 - Notes Payable**

During the year, the Company issued numerous promissory notes in relation to the pending
acquisition of eHDL, Inc. and to other unrelated parties for operating capital.  The total balance of
the notes is $220,010.  The notes bear interest between the rates of 8% and 10% per annum, some
of which are secured by the Company's common stock.  Several of the notes are due on demand
while others shall be due and payable within the next fiscal year.  At September 30, 2002, the total
accrued interest totaled $7,271.

---

**MedXLink, Corp.**

September			September

The Company has the following notes payable obligations:                
2002                   
2001

Convertible note payable to investor is due on 
 September 30, 2003 plus accrued interest at a rate of 8% per
annum, secured by common stock of the Company.                          
$		5,127            $		5,127

Convertible notes payable to investor are due on demand
plus accrued interest at a rate of 10% per annum.                                
19,883                 
-

Convertible notes payable to investors due within one year
plus accrued interest at a rate of 8% per annum.                                   
195,000-

Totals                                                                                               
$		220,010           $		5,127

Less Current Maturities                                                                     
(220,010)         
(5,127)

Total Long-Term Notes Payable                                                       
$	-                     
$	-

Following are maturities of long-term debt for each of the next five years:

Year	Amount

2003                           
$		220,010

2004                                   
-

2005                                   
-

2006                                   
-

Thereafter                                                         
-

Total                                                         
$		220,010

**NOTE 5 - Note Receivable**

The Company loaned eHDL, Inc., $195,000 in conjunction with the anticipated merger.  The note
bears an interest rate of 8% per annum and is due on demand.  As of September 30, 2002, the total
accrued interest is $3,788.

September         September
The Company has the following note receivable:                 
2002               
2001

Note Receivable to eHDL, Inc., due on demand
bearing interest at 8% per annum.                                    
$		195,000           
$	-

Totals                                                                                
195,000             
-

Less Current Maturities                                                    
(195,000)            
-

Total Long-Term Note Receivable                                   
$	-                      
$	-



---



**MedXLink, Corp.**

**NOTE 6 - Stockholders' Equity**

The Company's Articles of Incorporation were amended on July 12, 2002 to effect a 1:100 reverse
common stock split and eliminate the Class A and Class B Preferred stock, thereby decreasing the
total authorized shares from 101,000,000 to 100,000,000 maintaining a par value of $.001.  There were
no issued or outstanding shares of either class of preferred stock.  This change effecting the common
stock and additional paid in capital values  has been retroactively applied to all prior years.

Additional shares have been issued during the year due to rounding of the reverse stock split.  Any
shareholder with fewer than 100 shares was not effected by the split.

**NOTE 7 - Net Earnings (Loss) Per Share**

Basic earnings (loss) per common share (BEPS) is based on the weighted-average number of
common shares outstanding during each period.  Diluted earnings (loss) per common share is based
on shares outstanding (computed as under BEPS) and dilutive potential common shares.  Shares
from the exercise of the outstanding options were not included in the computation of diluted loss per
share, because their inclusion would have been antidilutive for the year ended September 30, 2002.

The following data shows the shares used in the computing loss per common share including dilutive
potential common stock;

Common shares outstanding during the entire period Weighted-average shares paid for, but not issued during the period.	251,445
Weighted-average number of common shares used in basic EPS dilutive effect of options
251,445  Weighted-average number of common shares and dilutive potential
common shares used in diluted EPS		251,445

Shares from the exercise of the outstanding options were not included in the computation of diluted
loss per share because their inclusion would have been antidilutive for the year ended September 30,
2002.

**NOTE 8 - Related Party Transactions**



---



**MedXLink, Corp.**

******NOTE 9 - Going Concern**

The Company's financial statements are prepared using generally accepted accounting principles
applicable to a going concern, which contemplates the realization of assets and liquidation of
liabilities in the normal course of business.  Currently, the Company does not have significant cash
or other material assets, nor does it have an established source of revenues sufficient to cover its
operating costs and to allow it to continue as a going concern.  The Company does not currently
possess a financial institution source of financing and the Company cannot be certain that it's
existing sources of cash will be adequate to meet its liquidity requirements.  However, the Company
is undertaking the following approach to meet its liquidity requirements.

(b)	The Company will seek to continue converting certain outstanding loans and
payables into common stock in order to reduce future cash obligations;

(c)	Management is identifying prospective acquisition targets with sufficient cash flow
to fund operations, as well as potentially generating operating cash flow that may
sustain corporate administrative expenses;

The Company's future capital requirements will depend on its ability to successfully implement these
initiatives.

Effective July 21, 2002 the Company entered into an agreement to acquire all of the equity of eHDL,
Inc. ("eHDL").  In anticipation of the transaction the Company sold approximately $195,000 in
debentures and loaned the proceeds to eHDL.  The transaction is not scheduled to close, however,
until and unless eHDL obtains 1) $1 million in funding, 2) converts its existing debt to equity and 3)
obtains audited financial statements.  Based on the current financial status of eHDL, management
does not anticipate it will complete the acquisition of eHDL.  Consequently, the Company may have
to seek bankruptcy protection to resolve debenture obligations created in anticipation of acquiring
eHDL.  Only if the debenture obligations are resolved will the Company be able to proceed with
finding a business opportunity to merge with or acquire.

**ITEM 8. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON
ACCOUNTING** **AND FINANCIAL DISCLOSURE**

On April 23, 2001, the client-auditor relationship between NTC Holdings, Inc. ("the
Company") and Crouch, Bierwolf & Associates ("Crouch") ceased as Crouch was dismissed as the
Company's auditor.

On April 23, 2001, the Company's boardf directors approved the engagement of Bierwolf,
Nilson & Associates as its independent accountants for the fiscal year ended September 30, 2001.



---



**PART III**



---

**Directors and Executive Officers**

Age                                           
Director Name                  (2001)             
Since             
Position with the Company

Dean Becker           47              
1997              
President, CEO and Director
4766 South Holladay Boulevard
Holladay, Utah 84117

He has a general law practice with emphasis on corporate and business law, and is involved in a
number of community activities.

**ITEM 10. EXECUTIVE COMPENSATION**

**Compensation of Executive Officers and Directors**

During the current fiscal year, no one in the Company's management received more than
$60,000 in compensation.

**Employment Agreements and Other Compensation Arrangements**

There are currently no agreements with members of management as to employment or
compensation.

**Compensation of Non-Employee Directors**

There is currently no compensation paid to non-employment directors.

**ITEM 11. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT**

|Name and Address

Of Beneficial Owner                              | Beneficial

Ownership | Percent of

Class
|------------------------------------------------------------------ | --------------------- | -----------------
|Dean Becker   

4766 South Holladay Boulevard
Holladay, Utah 84117 | 2,005,000             | 89.0%            
|Officers and Directors 

As a Group (one)                          | 2,005,000             | 89.0%            

During the fourth quarter Dean Becker, the Company's president, was issued 2,000,000 in
exchange for payment of $2,000 in the Company's accounts payable.

During the reported year the Registrant did not enter into any other transactions with
management which are to be reported under this Item.

**ITEM  13.    EXHIBITS AND REPORTS ON FORM 8-K.**

99.1  Written Statement of Chief Executive Officer and Chief Financial Officer with respect
        to compliance with Section 13(a) or 15(d) of  the Securities Exchange Act of 1934.

(b) The Registrant filed no current reports on Form 8-K during the last quarter of the fiscal
      year ended September 30, 2002.

**ITEM 14.**  **CONTROLS AND PROCEDURES.**

(a) Evaluation of disclosure controls and procedures.  The Company's principal executive
officer and its principal financial officer, based on their evaluation of the Company's disclosure
controls and procedures (as defined in Exchange Act Rules 13a-14 (c) as of a date within 90 days
prior to the filing of this Annual Report on Form 10KSB, have concluded that the Company's
disclosure controls and procedures are adequate and effective for the purposes set forth in the
definition in Exchange Act rules.

(b) Changes in internal controls.  There were no significant changes in the Company's
internal controls or in other factors that could significantly affect the Company's internal controls
subsequent to the date of their evaluation.

---

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly
authorized.

MedXLink, Corp.

By:   Dean Becker/s/ Dean Becker

Dated:January 14, 2003

---

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed
below by the following persons of behalf of the Registrant and in the capacities and on the dates
indicated.

SIGNATURE                                 
TITLE                                      
DATE



---



**SECTION 302 CERTIFICATION**

I, Dean Becker, certify that:

1. I have reviewed this annual report on Form 10-KSB of MedXLink, Corp.;

2. Based on my knowledge, this annual report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this annual report.

3.  Based on my knowledge, the financial statements, and other financial information included
in this annual report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this annual report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

a) Designed such disclosure controls and procedures to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this annual report is being prepared.

b) Evaluated the effectiveness of the registrant's disclosure controls and procedures as of a
date within 90 days prior to the filing date of this annual report (the "Evaluation Date"); and

c) Presented in this annual report our conclusions about the effectiveness of the disclosure
controls and procedures based on our evaluation as of the Evaluation Date;

5. I have disclosed, based on our most recent evaluation, to the registrant's auditors and the
audit committee of registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies in the design or operation of internal controls which could
adversely affect the registrant's ability to record, process, summarize and report financial data and
have identified for the registrant's auditors any material weaknesses in internal controls; and

b) Any fraud, whether or not material, that involves management or other employees who
have a significant role in the registrant's internal controls; and

6.  I have indicated in this annual report whether or not there were significant changes in
internal controls or in other factors that could significantly affect internal controls subsequent to the
date of our most recent evaluation, including any corrective actions with regard to significant
deficiencies and material weaknesses.

Date: January 14 , 2003                                                   /s/ 
Dean Becker
Chief Executive Officer
                                                                                       And Principle Accounting Officer

---

EXHIBIT 99.1



(1)The Report fully complies with the requirements of section 13 (a) or 15 (d) of the Securities
Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial
condition and result of operations of the Company.

Date: January 14, 2003
Dean Becker, Chief Executive Officer
And Principle Accounting Officer

---